動物用ワクチンの北米市場2020-2252

◆英語タイトル:NORTH AMERICA VETERINARY VACCINES MARKET FORECAST 2020-2028
◆商品コード:INK20MY303
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年2月
◆ページ数:156
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥135,000見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥216,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe market of veterinary vaccines of North America is predicted to register a CAGR of 6.01% during the projected period, 2020-2028. A surge in companion animal ownership and increasing government initiatives are the significant factors boosting the growth of the market in the region.

MARKET INSIGHTS
The North American market of veterinary vaccines is researched further by dividing the region into the US and Canada. In Canada, veterinary vaccines are regulated by the Canadian Food Inspection Agency. It is mandatory for all vaccines to be sold in Canada to be registered with the Canadian Centre for Veterinary Biologics. In 2005, to protect Atlantic salmon from hematopoietic necrosis, the first DNA vaccines for edible species were registered in Canada. Since 2008, the Veterinary Medical Association has revised vaccination protocols for cats and dogs. In Canada, most newborn calves are vaccinated with BVD vaccines, along with Clostridial vaccines. The Alberta Livestock and Meat Agency Ltd. is aiming at two pathogens, Salmonella and Clostridium perfringens, which affect poultry producers. Ceva produces VECTORMUNE, the broadest range of disease protection in a vector vaccine line of poultry vaccines against diseases, such as Marek’s disease, Newcastle Disease, Fowl Pox, Avian influenza, Mycoplasma, and Avian Encephalomyelitis. The International Development Research Centre started a Livestock Vaccines innovation Fund in 2015, in Canada, which tries to improve the health of livestock and livelihood of farmers, by supporting the production, development, and commercialization of innovative vaccines to fight neglected livestock diseases in Sub-Saharan Africa, South, and South-East Asia. These factors, along with innovation in the development of new animal vaccines, are contemplated to contribute to the growth of the Canadian market.

COMPETITIVE INSIGHTS
Virbac SA, Ceva Santé Animale, The Boehringer Ingelheim group, Merck & Co., Inc., Elanco, etc. are some of the prominent companies operating in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARIES
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. PROGRESSION IN THE VACCINE PRODUCTS
3.2.2. INCREASING GOVERNMENT INITIATIVES
3.2.3. INCREASING INCIDENCE OF ZOONOTIC DISEASES
3.2.4. SURGE IN THE COMPANION ANIMAL OWNERSHIP
3.2.5. GROWING PREVALENCE OF LIVESTOCK DISEASES
3.3. KEY RESTRAINTS
3.3.1. HIGH COST OF VACCINATIONS
3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
3.3.3. LACK OF SKILLED FARMWORKERS AND VETERINARIANS
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. VALUE CHAIN ANALYSIS
4.3. REGULATORY FRAMEWORK
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY VACCINE TYPE
5.1. LIVESTOCK VACCINE
5.1.1. PORCINE VACCINE
5.1.2. BOVINE VACCINE
5.1.3. POULTRY VACCINE
5.1.4. AQUACULTURE VACCINE
5.1.5. OTHER LIVESTOCK VACCINE
5.2. COMPANION VACCINE
5.2.1. CANINE VACCINE
5.2.2. FELINE VACCINE
5.2.3. EQUINE VACCINE
6. MARKET BY TECHNOLOGY
6.1. LIVE ATTENUATED VACCINE
6.2. INACTIVATED VACCINE
6.3. RECOMBINANT VACCINE
6.4. TOXOID VACCINE
6.5. OTHER TECHNOLOGY
7. MARKET BY DISEASE TYPE
7.1. CANINE DISEASE
7.2. PORCINE DISEASE
7.3. BOVINE DISEASE
7.4. POULTRY DISEASE
7.5. AQUACULTURE DISEASE
7.6. OTHER DISEASE TYPE
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA
9. COMPANY PROFILES
9.1. ANICON LABOR GMBH
9.2. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
9.3. CEVA SANTE ANIMALE
9.4. ELANCO (ELI LILLY AND COMPANY)
9.5. HESTER BIOSCIENCES LIMITED
9.6. HIPRA
9.7. HYGIEIA BIOLOGICAL LABORATORIES
9.8. MERCK & CO.
9.9. PHIBRO ANIMAL HEALTH CORP.
9.10. ROMVAC COMPANY S.A.
9.11. VAXXINOVA GMBH-GERMANY
9.12. VIRBAC SA
9.13. ZOETIS ANIMAL HEALTHCARE

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINE
TABLE 2: NORTH AMERICA VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: NORTH AMERICA VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: NORTH AMERICA LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA PORCINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES
TABLE 10: NORTH AMERICA PORCINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA BOVINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES
TABLE 13: NORTH AMERICA BOVINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA POULTRY VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES
TABLE 16: NORTH AMERICA POULTRY VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA AQUACULTURE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES
TABLE 19: NORTH AMERICA AQUACULTURE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA OTHER LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: NORTH AMERICA OTHER LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA COMPANION VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: NORTH AMERICA COMPANION VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 24: NORTH AMERICA COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: NORTH AMERICA COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 26: NORTH AMERICA CANINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES
TABLE 28: NORTH AMERICA CANINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 29: NORTH AMERICA FELINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES
TABLE 31: NORTH AMERICA FELINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 32: NORTH AMERICA EQUINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES
TABLE 34: NORTH AMERICA EQUINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 35: NORTH AMERICA VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 36: NORTH AMERICA VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 37: NORTH AMERICA LIVE ATTENUATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 38: NORTH AMERICA LIVE ATTENUATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 39: NORTH AMERICA INACTIVATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 40: NORTH AMERICA INACTIVATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 41: NORTH AMERICA RECOMBINANT VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 42: NORTH AMERICA RECOMBINANT VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 43: NORTH AMERICA TOXOID VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 44: NORTH AMERICA TOXOID VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 45: NORTH AMERICA OTHER TECHNOLOGY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 46: NORTH AMERICA OTHER TECHNOLOGY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 47: NORTH AMERICA VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 48: NORTH AMERICA VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 49: NORTH AMERICA CANINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 50: NORTH AMERICA CANINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 51: NORTH AMERICA PORCINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 52: NORTH AMERICA PORCINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 53: NORTH AMERICA BOVINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 54: NORTH AMERICA BOVINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 55: NORTH AMERICA POULTRY DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 56: NORTH AMERICA POULTRY DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 57: NORTH AMERICA AQUACULTURE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 58: NORTH AMERICA AQUACULTURE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 59: NORTH AMERICA OTHER DISEASE TYPE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 60: NORTH AMERICA OTHER DISEASE TYPE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 61: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 62: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: NORTH AMERICA VETERINARY VACCINES, BY VACCINE TYPE, IN 2019
FIGURE 5: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA VETERINARY VACCINES, BY TECHNOLOGY, IN 2019
FIGURE 16: NORTH AMERICA VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA VETERINARY VACCINES, BY DISEASE TYPE, IN 2019
FIGURE 22: NORTH AMERICA VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 26: NORTH AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)
FIGURE 28: NORTH AMERICA VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 29: THE UNITED STATES VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 30: CANADA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[動物用ワクチンの北米市場2020-2252]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆